(Q51984235)
Statements
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. (English)
1 reference
Revicki DA
1 reference
Moyle G
1 reference
Stellbrink HJ
1 reference
Barker C
1 reference
1 May 1999
1 reference
1 reference
13
1 reference
7
1 reference
851-858
1 reference